Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-042111
Filing Date
2017-06-28
Accepted
2017-06-28 16:12:48
Documents
1
Period of Report
2017-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2775
  Complete submission text file 0001209191-17-042111.txt   4244
Mailing Address 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105
Business Address
Gambhir Sanjiv Sam (Reporting) CIK: 0001369005 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37969 | Film No.: 17935364

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Issuer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus